Recovery pathway
Deep Sleep
DSIP & Sermorelin
Laboratory verification
Nothing unverified is published
Every compound is prepared to a documented standard. Independent certificates of analysis are published here per batch as they are verified under Nuragen's own governance, we do not reuse another brand's certificates or purity figures.
Certificate of analysis · per batch · on request
Verification-led release
Deep Sleep is a research-use-only pairing of two peptides, DSIP and Sermorelin. It is supplied for laboratory investigation of the recovery pathway and is not intended for human or animal use.
How it is studied
In the research literature, DSIP and Sermorelin are examined as distinct signalling molecules that intersect with sleep architecture and the growth-hormone axis. DSIP (delta sleep-inducing peptide) is studied for its association with slow-wave sleep patterns and neuromodulatory signalling. Sermorelin is investigated as a growth-hormone-releasing hormone analogue that acts on receptors in the pituitary. This pairing lets researchers observe how the two components behave as reference materials under controlled laboratory conditions.
The components and the pathway
DSIP is a naturally occurring peptide first isolated from mammalian brain tissue and named for its historical association with delta-wave sleep in early research. Sermorelin corresponds to the active fragment of growth-hormone-releasing hormone and is studied for how it signals the pituitary to release growth hormone. Both sit within what NURAGEN groups as the recovery pathway, reflecting the biological systems they are thought to act upon. Deep Sleep presents them together as a single research item for comparative and mechanistic study.
Its place in a responsible research programme
Deep Sleep is intended for qualified researchers working within appropriate institutional or laboratory settings. It is characterised as a reference compound for in-vitro and preclinical investigation, not as anything to be administered. Responsible use means documenting handling, storage and experimental context so that observations remain traceable. NURAGEN supplies the material and the factual description; the research design and its governance remain with the investigator.
Composition
| Component | CAS | Purity |
|---|---|---|
| DSIP | 62568-57-4 | Pending |
| Sermorelin | 86168-78-7 | Pending |
| Type | Lyophilised powder |
|---|---|
| Presentation | Lyophilised powder |
| Appearance | White lyophilised powder |
| Storage | Store at 2-8°C, protected from light. |
| Dispatch | Delivered within 72 hours across the UK. |
Handling should follow standard laboratory practice and your own institutional protocols. No dosing, administration or medical guidance is provided.
Deep Sleep is a research pairing of the peptides DSIP and Sermorelin, supplied strictly for research-use-only purposes. It is intended for qualified investigators in laboratory settings and is not for human or animal use, consumption or administration of any kind.
As a general practice for peptide reference materials, storage at 2-8C and protection from light and moisture help preserve integrity. Handling should follow your laboratory's standard procedures for research chemicals, including appropriate protective equipment and documentation. Always defer to the specifications provided with your material.
No. NURAGEN provides factual, process-based descriptions of what a compound is and the pathways it is studied to act on. We do not provide dosing, administration protocols, clinical guidance or medical advice, because these materials are not intended for use in people or animals.
The two are grouped because each is studied within the recovery pathway from a different angle: DSIP for its association with sleep-related signalling, and Sermorelin for its action on the growth-hormone-releasing pathway. Pairing them as a single research item supports comparative and mechanistic study of that shared context.
In context
Evidence before action
Peptides associated with sleep and the growth-hormone axis attract interest precisely because their signalling is intricate, and much of what is understood about DSIP and Sermorelin comes from a research literature that is still developing. We describe what these compounds are and the pathways they are thought to act on, rather than what any reader might expect from them. That distinction matters: sound conclusions come from controlled study and peer review, not from assumption. Reading the mechanism carefully, and treating claims as questions to be tested, is what keeps research accountable.
Related pathways
Explore alongside
Recovery
Growth Signal
Paired CJC-1295 and Ipamorelin peptides studied within the recovery pathway.
£160
Recovery
Repair
A focused research pair of BPC-157 and TB-500, studied within tissue-repair pathways.
£140
Longevity
Regenesis
Proprietary multi-component longevity blend studied for research use only.
£270
Recovery
Wolverine
Proprietary recovery-pathway blend of tissue-repair and remodelling peptides, held for research use.
£170